Pharmaceuticals And Biotech Are A Hot Space For Activists Right Now
Since it has been a relatively quiet week – for proxy season, at least – I want to provide a little bit more insight into one of our two feature articles from the April issue. It’s something of an irony that just as Bill Ackman decides to get out of Valeant Pharmaceuticals International, the rest of the activist community appears to be refocusing on the sector. Perhaps it’s a function of real estate faltering a little or oil prices failing to stabilize (though the outlook is better than it was a while ago). Perhaps it has to do with Trump...
This content is exclusively for paying members of Hedge Fund Alpha
Gain Exclusive Access to the Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha Get Started Now with a FREE 7-Day Trial🔻If you are a current Hedge Fund Alpha member and are having an account error please clear cache and cookies. If that does not work, email [email protected] or click Chat. |
